This app is the ACC’s mobile home for clinical guideline content and tools for clinicians caring for patients with cardiovascular disease. Current guidelines in the App include:
• Atrial Fibrillation (AF)
• Cardiovascular Risk (CV Risk)
• Cholesterol (Chol)
• Heart Failure (HF)
• Lifestyle (Lstyle)
• Valvular Heart Disease (VHD)
Stay tuned for ongoing updates, more guideline content, and tools.
Send feedback to the ACC directly from the App Information page or post a review in the App Store. Help us find new and better ways to deliver guideline content to clinicians.
These guidelines will be cached on the phone/tablet on first use or you can download them in advance - WiFi is advised for this but not enforced.
Great for use in areas where reception is poor or you can't get to a PC.
The lead developer Dr Joshi can be contacted directly at firstname.lastname@example.org.
Alternatively pop by the website: http://openhealthcare.org.uk
If you want this app. improved then please post your comments, problems or requests to this website:
If you're up to coding yourself then please join in.
We are aware that recent models of Samsung (i.e. the S3 and onwards) address their SDCard in an idiosyncratic way that will cause the app to crash ungracefully. This was a specific Samsung problem which they have addressed in their update.
Please note the comments in the Recent changes box.
ACP is a national organization of internists —physician specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness. ACP is the largest medical-specialty organization and second-largest physician group in the United States. Its membership of 133,000 includes internists, internal medicine subspecialists, medical students, residents, and fellows. The mission of the ACP is to enhance the quality and effectiveness of health care by fostering excellence and professionalism in the practice of medicine.
SCCM is the largest multiprofessional organization dedicated to ensuring excellence and consistency in the practice of critical care.
NCCN is pleased to present the Virtual Library of NCCN Guidelines® Formatted for Android Smartphone. This easy to use and convenient format will further assist health care professionals in their implementation of the NCCN Guidelines, thus improving the quality and effectiveness of care provided to patients with cancer. NCCN invites you to explore the NCCN Guidelines in this exciting new format.
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 23 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
Over the past 15 years, NCCN has developed an integrated suite of tools to improve the quality of cancer care. The NCCN Guidelines document evidence-based, consensus-driven management to ensure that all patients receive preventive, diagnostic, treatment, and supportive services that are most likely to lead to optimal outcomes.
The NCCN Guidelines are a comprehensive set of guidelines detailing the sequential management decisions and interventions for the malignant cancers that affect 97 percent of all patients with cancer. In addition, separate guidelines relate to major prevention and screening topics and another set of pathways focuses on the major supportive care areas.
The NCCN Guidelines are composed of recommendations based on the best evidence available at the time they are derived. Because new data are published continuously, it is essential that the NCCN Guidelines also be continuously updated and revised to reflect new data and new clinical information. The goal of the NCCN Guidelines is to help oncologists make the major clinical decisions encountered in managing their patients by providing ready access to synthesized information. The NCCN Guidelines provide recommendations for appropriate care for most but not all patients; however, individual patient circumstances must be considered when applying these recommendations.
Visit NCCN.org to learn more about the NCCN Guidelines as well as other NCCN Content.
Updated: December 2014
SIGN guideline recommendations are available on the move with the award-winning SIGN app. Developed by the SIGN Executive in collaboration with Root Creative, Glasgow.
New content includes:
• Send PDF button, send a PDF version of the Guideline you are viewing to a mailbox address.
• Split screen viewing and browsing (iPad only).
New content includes:
SIGN 141: British guideline on the management of asthma
Produced jointly by SIGN and the British Thoracic Society (BTS) since 2003, sections of the guideline are updated biennially. The 2014 update covers all sections of the guideline except diagnosis/monitoring and asthma in adolescents and includes complete revisions of the sections on supported self-management and organisation and delivery of care, and extensive revisions to the section on non-pharmacological management of asthma.
A new section highlighting the key recommendations for implementation has also been added. It is hoped that this asthma guideline continues to serve as a basis for high quality management of both acute and chronic asthma and a stimulus for research into areas of management for which there is little evidence.
Sections of the guideline will continue to be updated on the BTS and SIGN websites on a biennial basis.
The QRG content is enhanced with material from the main guideline and online resources, linked to the SIGN website. The app features keyword search, bookmarking and access to the SIGN website. New QRGs will be available as an update as they are published, building into a complete library.
Main web site:
Support web site:
The Clinical Excellence Commission Sepsis Adult FIRST DOSE Empirical Intravenous Antibiotic Guideline aims to guide the prescription and timely administration of the FIRST DOSE of intravenous (IV) antibiotics for adult patients who have a diagnosis of sepsis. The guideline is based on the Therapeutic Guidelines: Antibiotic version 14, 2010 Prophylactic, empirical or directed antimicrobial therapy and incorporates best available evidence and the principles of appropriate use of antibiotics.
Best practice, anytime, anywhere.
The Guidelines in Practice journal provides UK-based healthcare professionals with evidence-based articles and content on best clinical practice. The new Guidelines in Practice app contains all the regular journal content in a fully searchable format.
The Guidelines in Practice app is available free-of-charge to healthcare professionals with an eGuidelines.co.uk account. To claim your free subscription, simply download the app and enter your email address and eGuidelines.co.uk password within the login section of the Subscriber Management page to gain access to all of the journal content. If you have any questions during the login process, simply visit the FAQs tab directly above the login screen. (NB for healthcare professionals who do not have an eGuidelines.co.uk account, registration is free at www.eGuidelines.co.uk)
If you are not a healthcare professional, you can purchase access to all of the content on the Guidelines in Practice app for one month for £2.99. Alternatively you can choose to purchase a 6/12 month subscription to all of the app content.
Articles in Guidelines in Practice are written by experts and provide a practical perspective on clinical topics, along with key points, commissioning messages, and CPD-related content. With the Guidelines in Practice app you can keep up to date with evidence-based recommendations whenever, wherever you are.
Key features of the Guidelines in Practice app include:
• evidence-based, independent, fully searchable content
• quick access to quality content
• bookmarking features
• articles on:
-new guidance and evidence
-clinical case studies
• key points and commissioning messages associated with content
• coverage across all clinical areas, including:
-inflammatory bowel disease
• CPD features
• content sharing facility.
It is the first ever app to contain public health guidance, including topics such as smoking cessation, promoting physical activity, behaviour change and preventing diabetes. It contains all of NICE’s clinical guidelines, including those on COPD, hypertension, stroke, chronic heart failure, atrial fibrillation, head injury, depression, ovarian cancer, UTI in children, anxiety and autism. It also contains all NICE’s technology appraisals, interventional procedures guidance, medical technology and diagnostics guidance.
* Search, browse and explore all of NICE’s current guidance
* Bookmark sections for easy access
* Email sections to yourself or colleagues
NICE provides authoritative, evidence-based guidance on the most effective way to diagnose, treat and prevent disease and ill health. Our guidance is for the UK National Health Service (NHS), local authorities, charities, and anyone with a responsibility for commissioning or providing healthcare. NICE is government-funded through the UK’s Department of Health.
The NICE Guidance app covers:
Conditions and diseases
* Blood and immune system
* Central nervous system
* Digestive system
* Ear and nose
* Endocrine, nutritional and metabolic
* Gynaecology, pregnancy and birth
* Infectious diseases
* Injuries, accidents and wounds
* Mental health and behavioural conditions
* Mouth and dental
* Accidents and injuries
* Behaviour change
* Cardiovascular disease
* Child health
* Child social care
* Chronic illness
* Environmental health
* Infectious diseases
* Maternal health
* Mental health
* Non-communicable diseases
* Obesity and diet
* Occupational health
* Older people
* Physical activity
* Sexual health
* Smoking and tobacco
* Vaccine preventable diseases
* Working with and involving communities
NOTE: This app is primarily aimed at healthcare and other professionals. For information on resources available from NICE for patients and the public, visit our website at http://www.nice.org.uk/getinvolved/patientsandpublic
1. Install and run main application: our "Nice Guidelines" app
2. Install and run this app. Click the button
Just put age, and BP settings as well as check whether Diabetes or Kidney Disease is present or not and the tool guides through the treatment options.
Up-to-date tool for evidence based management of hypertension (elevated blood pressure).
Treatment medications with dosing added.
Great tool for treatment of high blood pressure.
Disclaimer: Developer carries no liability for medical decisions made by users of this application.
Please leave your feedback.
Check out our other apps.
1-PFT Interpreter and COPD Treatment Tool.
2-Lung Cancer Staging 7th ed.
3-Diabetes Mellitus II Treatment Algorithm.
4-Code911 App for Emergency Communication with contacts and 911.
Disclaimer: The developer is not liable for any decisions made by users of these applications.
Please note, the included guidelines are for reference purposes only and may not be the most up to date, use the import functionality to add guidelines for a new trust.
- Ability to import new trust guidelines
- Gentamicin calculator
- Add personal notes to infections
- Colour coding for drugs
Please email if you need help, or have any questions.
The Guidelines app has won Directory of the Year at the 2013 PPA Digital Publishing Awards.
The app contains concise clinical guideline summaries of all the major primary and shared care guidelines in the UK. The app is designed for healthcare professionals and suitable for use on Android phones and tablets, is completely searchable, and contains all the content from the well-respected Guidelines handbook. With this app you can reach all the summaries in just three taps.
This useful app will allow all healthcare professionals immediate access to summaries of NICE, independent professional body, and expert-led working party guidelines. Users will be able to bookmark their most used/favourite guidance, and will be able to follow treatment/management algorithms through a series of helpful diagnostic questions.
Key features of the app include:
• Respected handbook content
• Quick access to summaries in just three taps
• Android phone- and tablet-compatible
• Fully searchable
• No requirement for an Internet connection
• Bookmark feature to keep track of most used/favourite summaries
• Content is updated three times each year
• Notes feature to annotate relevant summaries.
The summaries in the app are divided up into the following sections:
• Central nervous system
• Obstetrics, gynaecology & urology
• Malignant disease
• Musculoskeletal & joints
• Eye, ear, nose & throat
• Immunisation & vaccination
The development of the app has been supported by sponsorship from AstraZeneca. AstraZeneca had no input into the design or development of the app. Content for the Guidelines handbook and app has been developed independently by MGP Ltd with no input from AstraZeneca.
Contact us: We cannot reply to your comments in Google play. Please email us directly on email@example.com if you have any questions or experience problems purchasing or accessing content.
• Videos that provide an overview of the 2012 HF guideline updates.
• Recommendations with key figures and tables
• Tools (PRIDE Acute HF Score & Framingham Heart Score)
• Useful drug and treatment information
• Landmark heart failure clinical trial summaries and key references
• Guideline library that contains all the CCS HF & CRT Guidelines and Updates between 2002-2013
Note: The default keyboard on certain devices may not contain a comma, which is needed for some tools. If so, please install the default Google Keyboard: https://play.google.com/store/apps/details?id=com.google.android.inputmethod.latin
The multi-disciplinary guideline development group consisted of general practitioners, hospital consultant medical microbiologists, a consultant in HIV / genito-urinary medicine, specialist hospital microbiology / infectious diseases pharmacists, primary care trust and ambulance trust pharmacists and a senior podiatrist across Southampton, Hampshire, Isle of Wight and Portsmouth.
The guidelines are based largely on the Management of Infection Guidance for Primary Care, published jointly by the Health Protection Agency and the British Infection Association and the guideline development group gratefully acknowledges the work of Dr Cliodna McNulty and her colleagues in the HPA and BIA.
Recommendations for when antimicrobial treatment is indicated, based upon cited national or international evidence-based guidelines, have been expanded from the HPA/BIA Guidance, along with recommendations and practical advice for taking specimens for microbiological investigations and interpreting culture and sensitivity laboratory reports. Clinically relevant information on cautions and warnings associated with antimicrobial treatment have also been expanded from the HPA/BIA Guidance including information about risk of Clostridium difficile infection. All statements are fully referenced.